Immunotherapy Reverses Multiple Sclerosis in Mice

Hoffman noted that it would be a minimum of 5 years before their approach is made available to individuals with MS. “Although the liver-directed gene therapy platform is clinically used to treat other diseases, this particular application is complex and may require additional testing” he said.

References

http://www.alligator.org/news/article_f3aa2ace-a705-11e7-b620-77fa35f61356.html

https://ghr.nlm.nih.gov/primer/therapy/genetherapy

https://www.genengnews.com/gen-news-highlights/gene-immunotherapy-reverses-paralysis-in-mouse-model-of-multiple-sclerosis/8125495

https://www.eurekalert.org/pub_releases/2017-09/cp-gip091417.php

https://multiplesclerosisnewstoday.com/2017/09/25/ms-gene-therapy-shows-excellent-results-in-mice-but-human-trials-remain-distant/

https://www.sciencedaily.com/releases/2017/09/170921161240.htm

https://www.leafscience.org/gene-therapy-for-ms/

https://www.medicalnewstoday.com/articles/319469.php